{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:18:27Z","timestamp":1785770307850,"version":"3.56.0"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"13","license":[{"start":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T00:00:00Z","timestamp":1617321600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Backgroud:<\/jats:title>\n            <jats:p>Previous studies have reported that the levels of L1 cell adhesion molecule (L1CAM) indicate poor prognosis of patients with various solid tumors. However, the prognostic significance of L1CAM in endometrial cancer has remained controversial. Herein, we conducted a systematic review and meta-analysis to evaluate the prognostic value of L1CAM in endometrial cancer.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>All studies related to the association between L1CAM expression and clinical characteristics of endometrial cancer were identified by searching the PubMed, MEDLINE, EMBASE, and Web of Science databases. Primary outcomes of the meta-analysis were the hazard ratios (HRs) for overall survival (OS) and disease-free survival (DFS). Secondary outcomes were odds ratios (ORs) for clinicopathological characteristics. Publication bias and sensitivity analysis were conducted to ensure reliability of the results.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Overall, 17 studies encompassing 7146 patients were eligible for the meta-analysis. Results showed L1CAM overexpression to be significantly associated with decreased overall survival (HR\u200a=\u200a2.87, 95% CI; 1.81\u20134.55, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001) and disease-free survival (HR\u200a=\u200a3.32, 95% CI; 1.99\u20135.55, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001) in patients with endometrial cancer. High L1CAM expression was also related to adverse clinicopathological characteristics.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>This systematic review demonstrated that high L1CAM expression is correlated with poor survival outcomes and adverse clinicopathological parameters in patients with endometrial cancer.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000025330","type":"journal-article","created":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T13:09:01Z","timestamp":1617196141000},"page":"e25330","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":16,"title":["High L1CAM expression predicts poor prognosis of patients with endometrial cancer"],"prefix":"10.1097","volume":"100","author":[{"given":"Min","family":"Guo","sequence":"first","affiliation":[{"name":"Department of Gynecology and Obstetrics, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second University Hospital, Sichuan University"},{"name":"Department of Gynecology, University Hospital, University of Electronic Science and Technology of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Gong","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second University Hospital, Sichuan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Nie","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, The Affiliated Hospital of Southwest Medical University."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5542-6207","authenticated-orcid":false,"given":"Zhengyu","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second University Hospital, Sichuan University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,4,2]]},"reference":[{"key":"R1-20250524","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"R2-20250524","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s13046-018-0816-1","article-title":"Endometrial cancer prognosis correlates with the expression of L1CAM and miR34a biomarkers","volume":"37","author":"Corrado","year":"2018","journal-title":"J Exp Clin Cancer Res"},{"key":"R3-20250524","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/ijgo.12612","article-title":"Cancer of the corpus uteri","volume":"143","author":"Amant","year":"2018","journal-title":"Int J Gynaecol Obstet"},{"key":"R4-20250524","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1097\/AOG.0b013e31825bc3b4","article-title":"Endometrioid endometrial carcinoma with atrophic endometrium and poor prognosis","volume":"120","author":"Geels","year":"2012","journal-title":"Obstet Gynecol"},{"key":"R5-20250524","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1600-0463.2009.02467.x","article-title":"Biologic markers in endometrial cancer treatment","volume":"117","author":"Engelsen","year":"2009","journal-title":"APMIS"},{"key":"R6-20250524","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.ygyno.2017.06.010","article-title":"L1CAM expression associates with poor outcome in endometrioid, but not in clear cell ovarian carcinoma","volume":"146","author":"Soovares","year":"2017","journal-title":"Gynecol Oncol"},{"key":"R7-20250524","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00428-018-2444-8","article-title":"L1CAM expression in uterine carcinosarcoma is limited to the epithelial component and may be involved in epithelial-mesenchymal transition","volume":"473","author":"Versluis","year":"2018","journal-title":"Virchows Archiv"},{"key":"R8-20250524","doi-asserted-by":"crossref","first-page":"421","DOI":"10.21873\/anticanres.13128","article-title":"L1CAM as a negative prognostic factor in endometrioid endometrial adenocarcinoma FIGO stage IA-IB","volume":"39","author":"Klat","year":"2019","journal-title":"Anticancer Res"},{"key":"R9-20250524","doi-asserted-by":"crossref","first-page":"85196","DOI":"10.18632\/oncotarget.13236","article-title":"Prognostic significance of L1 cell adhesion molecule in cancer patients: a systematic review and meta-analysis","volume":"7","author":"Hua","year":"2016","journal-title":"Oncotarget"},{"key":"R10-20250524","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/bjc.2016.235","article-title":"L1CAM expression in endometrial carcinomas: an ENITEC collaboration study","volume":"115","author":"van der Putten","year":"2016","journal-title":"Br J Cancer"},{"key":"R11-20250524","doi-asserted-by":"crossref","first-page":"g7647","DOI":"10.1136\/bmj.g7647","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"350","author":"Shamseer","year":"2015","journal-title":"BMJ"},{"key":"R12-20250524","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.2147\/CMAR.S169558","article-title":"The efficacy and safety of olaparib in the treatment of cancers: a meta-analysis of randomized controlled trials","volume":"10","author":"Guo","year":"2018","journal-title":"Cancer Manag Res"},{"key":"R13-20250524","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/IGC.0000000000001187","article-title":"Added value of estrogen receptor, progesterone receptor, and L1 cell adhesion molecule expression to histology-based endometrial carcinoma recurrence prediction models: an ENITEC Collaboration study","volume":"28","author":"van der Putten","year":"2018","journal-title":"Int J Gynecol Cancer"},{"key":"R14-20250524","doi-asserted-by":"crossref","first-page":"e0209294","DOI":"10.1371\/journal.pone.0209294","article-title":"L1 cell adhesion molecule (L1CAM) expression in endometrioid endometrial carcinomas: a possible pre-operative surrogate of lymph vascular space invasion","volume":"13","author":"de Freitas","year":"2018","journal-title":"PLoS One"},{"key":"R15-20250524","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/his.13405","article-title":"The significance of L1CAM expression in clear cell carcinoma of the endometrium","volume":"72","author":"Fadare","year":"2018","journal-title":"Histopathology"},{"key":"R16-20250524","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1097\/IGC.0000000000001043","article-title":"Preoperative risk stratification of endometrial carcinoma: L1CAM as a biomarker","volume":"27","author":"Pasanen","year":"2017","journal-title":"Int J Gynecol Cancer"},{"key":"R17-20250524","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/bjc.2017.235","article-title":"Expression of L1CAM in curettage or high L1CAM level in preoperative blood samples predicts lymph node metastases and poor outcome in endometrial cancer patients","volume":"117","author":"Tangen","year":"2017","journal-title":"Br J Cancer"},{"key":"R18-20250524","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1016\/j.ejca.2014.07.014","article-title":"L1 cell adhesion molecule is a strong predictor for distant recurrence and overall survival in early stage endometrial cancer: pooled PORTEC trial results","volume":"50","author":"Bosse","year":"2014","journal-title":"Eur J Cancer"},{"key":"R19-20250524","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s12253-016-0047-8","article-title":"L1CAM expression is related to non-endometrioid histology, and prognostic for poor outcome in endometrioid endometrial carcinoma","volume":"22","author":"Geels","year":"2016","journal-title":"Pathol Oncol Res"},{"key":"R20-20250524","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1093\/jnci\/djt144","article-title":"L1CAM in early-stage type I endometrial cancer: results of a large multicenter evaluation","volume":"105","author":"Zeimet","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"R21-20250524","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/modpathol.2015.147","article-title":"Prognostic significance of L1CAM expression and its association with mutant p53 expression in high-risk endometrial cancer","volume":"29","author":"Van Gool","year":"2016","journal-title":"Mod Pathol"},{"key":"R22-20250524","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1186\/s12885-016-2631-4","article-title":"L1CAM as a prognostic marker in stage I endometrial cancer: a validation study","volume":"16","author":"Smogeli","year":"2016","journal-title":"BMC Cancer"},{"key":"R23-20250524","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1097\/IGC.0000000000000801","article-title":"L1 cell adhesion molecule as a predictor of disease-specific survival and patterns of relapse in endometrial cancer","volume":"26","author":"Pasanen","year":"2016","journal-title":"Int J Gynecol Cancer"},{"key":"R24-20250524","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/PGP.0000000000000338","article-title":"L1CAM and HER2 expression in early endometrioid uterine cancer","volume":"36","author":"Abdel Azim","year":"2017","journal-title":"Int J Gynecol Pathol"},{"key":"R25-20250524","doi-asserted-by":"crossref","first-page":"40221","DOI":"10.18632\/oncotarget.9574","article-title":"Evaluating L1CAM expression in human endometrial cancer using qRT-PCR","volume":"7","author":"Notaro","year":"2016","journal-title":"Oncotarget"},{"key":"R26-20250524","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ygyno.2016.02.003","article-title":"L1CAM is an independent predictor of poor survival in endometrial cancer: an analysis of The Cancer Genome Atlas (TCGA)","volume":"141","author":"Dellinger","year":"2016","journal-title":"Gynecol Oncol"},{"key":"R27-20250524","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.3892\/ijo.2015.2944","article-title":"Epithelial-to-mesenchymal transition in paired human primary and recurrent glioblastomas","volume":"46","author":"Kubelt","year":"2015","journal-title":"Int J Oncol"},{"key":"R28-20250524","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.canlet.2008.12.021","article-title":"L1 cell adhesion molecule (L1CAM) in invasive tumors","volume":"282","author":"Raveh","year":"2009","journal-title":"Cancer Lett"},{"key":"R29-20250524","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(15)00130-0","article-title":"Endometrial cancer","volume":"387","author":"Morice","year":"2016","journal-title":"Lancet"},{"key":"R30-20250524","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/S0140-6736(12)60442-5","article-title":"Contemporary management of endometrial cancer","volume":"379","author":"Wright","year":"2012","journal-title":"Lancet"},{"key":"R31-20250524","first-page":"Cd007585","article-title":"Lymphadenectomy for the management of endometrial cancer","volume":"10","author":"Frost","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"R32-20250524","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.eururo.2016.12.003","article-title":"The benefits and harms of different extents of lymph node dissection during radical prostatectomy for prostate cancer: a systematic review","volume":"72","author":"Fossati","year":"2017","journal-title":"Eur Urol"},{"key":"R33-20250524","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1471-2199-11-64","article-title":"L1CAM expression in endometrial carcinomas is regulated by usage of two different promoter regions","volume":"11","author":"Pfeifer","year":"2010","journal-title":"BMC Mol Biol"},{"key":"R34-20250524","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12885-018-5264-y","article-title":"Pretreatment thrombocytosis predict poor prognosis in patients with endometrial carcinoma: a systematic review and meta-analysis","volume":"19","author":"Nie","year":"2019","journal-title":"BMC Cancer"},{"key":"R35-20250524","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1200\/JCO.2018.78.0858","article-title":"Gonadotropin-releasing hormone agonists during chemotherapy for preservation of ovarian function and fertility in premenopausal patients with early breast cancer: a systematic review and meta-analysis of individual patient-level data","volume":"36","author":"Lambertini","year":"2018","journal-title":"J Clin Oncol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000025330","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T17:11:19Z","timestamp":1748106679000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000025330"}},"subtitle":["A systematic review and meta-analysis"],"short-title":[],"issued":{"date-parts":[[2021,4,2]]},"references-count":35,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000025330","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,2]]},"assertion":[{"value":"2020-03-09","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-19","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}